Condition
Haploidentical Hematopoietic Stem Cell Transplant clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Haploidentical Hematopoietic Stem Cell Transplant clinical trials that are recruiting, at sites in 2 countries (most in United States (1), India (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Lower Dose Cyclophosphamide After Haploidentical Stem Cell Transplant
This trial tests whether giving half the usual amount of cyclophosphamide after haploidentical stem cell transplantation can still prevent GVHD in adults with blood cancers.
-
Ruxolitinib-enhanced haploidentical transplant for children and young adults with sickle cell disease
This trial will test whether adding ruxolitinib to a reduced-intensity haploidentical transplant lowers the risk of graft failure in children and young adults with sickle cell disease.
Related topics
Quick answers
How many Haploidentical Hematopoietic Stem Cell Transplant clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.